Samsung Medical Center: Stomach Neoplasms trials

The registry lists 38 Stomach Neoplasms studies with Samsung Medical Center as lead sponsor. 4 are open to participants now and 1 have results posted.

Phase 1 5Phase 2 15Phase 3 8No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric CancerRecruitingNCT07607119Not applicable
• Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)RecruitingNCT07161479Not applicable
• The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)RecruitingNCT04798820Not applicable
• Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma PatientsRecruitingNCT04665687
• Pembrolizumab Plus Ramucirumab in Metastatic Gastric CancerCompletedNCT04632459Phase 2Results posted
• Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric CancerCompletedNCT07009600
• Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)WithdrawnNCT05431244Not applicable
• Postoperative Prognosis Management Service Based mHealth for Gastric Cancer PatientsStatus unknownNCT04907591Not applicable
• Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 PositiveActive, not recruitingNCT04249739Phase 2
• Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric CancerCompletedNCT03170180Phase 2
• A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard ChemotherapyStatus unknownNCT03086291Phase 1
• Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line ChemotherapyTerminatedNCT03082833Phase 2
• Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line TherapyTerminatedNCT03061708Phase 2
• Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO OverexpressionCompletedNCT03052478Phase 2
• Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor BiomarkerCompletedNCT02848066
• Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line ChemotherapyCompletedNCT02451956Phase 2
• A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node DissectionStatus unknownNCT02311595Phase 2
• The Screening Protocol for The VIKTORY TrialCompletedNCT02299648Not applicable
• Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver MetastasisCompletedNCT02015169Phase 2
• Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II TrialStatus unknownNCT01761461Phase 3
• Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric CancerWithdrawnNCT01470742Phase 3
• Pharmacogenomic Study (Adjuvant Chemotherapy)CompletedNCT01470404
• HER2 Circulating Tumor Cells in Gastric CancerCompletedNCT01299688
• Sunitinib + Docetaxel as Second-line Treatment in Gastric CancerCompletedNCT01238055Phase 2
• The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer SurgeryStatus unknownNCT01179750Phase 3
• Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled TrialStatus unknownNCT01179724Not applicable
• Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal DissectionStatus unknownNCT01157598Phase 3
• A Study of Pazopanib With CAPEOX in AGC PatientsCompletedNCT01130805Phase 2
• Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RTTerminatedNCT01106066Phase 1/2
• A Trial of RAD001/Capecitabine in Refractory Gastric CancerCompletedNCT01099527Phase 1/2
• Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer PatientsCompletedNCT01099085Phase 3
• Obestatin Change in Distal GastrectomyCompletedNCT00822718
• Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric CancerCompletedNCT00821990Phase 3
• Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)CompletedNCT00743964Phase 2
• Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal SeedingCompletedNCT00539877Phase 1
• A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric CancerCompletedNCT00533533Phase 1/2
• Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaCompletedNCT00323830Phase 3
• Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric CancerCompletedNCT00313872Phase 3